Raymond James & Associates’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $368K | Sell |
80,706
-5,353
| -6% | -$24.4K | ﹤0.01% | 3267 |
|
|
2024
Q2 | $374K | Buy |
86,059
+1,010
| +1% | +$4.39K | ﹤0.01% | 3218 |
|
|
2024
Q1 | $427K | Sell |
85,049
-2,000
| -2% | -$10K | ﹤0.01% | 3131 |
|
|
2023
Q4 | $546K | Buy |
87,049
+5,377
| +7% | +$33.7K | ﹤0.01% | 2894 |
|
|
2023
Q3 | $582K | Buy |
81,672
+4,420
| +6% | +$31.5K | ﹤0.01% | 2785 |
|
|
2023
Q2 | $787K | Buy |
77,252
+7,401
| +11% | +$75.4K | ﹤0.01% | 2613 |
|
|
2023
Q1 | $634K | Buy |
69,851
+18,093
| +35% | +$164K | ﹤0.01% | 2754 |
|
|
2022
Q4 | $371K | Buy |
+51,758
| New | +$371K | ﹤0.01% | 3071 |
|